Biotech Hot in July Driven by Positive Drug Data and Acquisitions
... offering of over $310 million. Other major biotech movers included: - Targacept closed out ... TC-5214, significantly improved symptoms of major depressive disorder for patients who did not ... helped people lose weight in all three of its major clinical trials. That should clear the way for ...Sanofi-aventis Announces Second Quarter 2009 Results
... of around 10% at constant exchange rates, barring major adverse events (1) Growth in ... items, at constant exchange rates and barring major adverse events 2009 second-quarter ... the prevention of papillomavirus infections (a major cause of cervical cancer), were down 27.4% at ...Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
... are slowly increasing to 14 years, though major pharmaceutical companies (those that spent more ... Factbook is based on primary sources covering major pharmaceutical companies which account for ... organization. With headquarters in New York and major operations in London and Eagan, Minnesota, ...China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
... number of outlets to 106 in Shanghai and 12 other major cities in China -- Expanded number of bulk ... be able to accept larger purchase orders from major dairy producers and animal feed manufacturers, ... plans to launch 300 Shining brand stores in major cities in China. Currently, China-Biotics is ...REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients
... (mirtazapine)15 mg Tablets for the treatment of major depressive disorder.(1) The product was developed ... is indicated for the treatment of major depressive disorder (MDD) in adults. ... and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric ...Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
... The authors' research shows that disruptions at major terminals could be significant under CSI. If ... port terminals for inspection could lead to major congestion. The current CSI protocol relies on ... limited throughput. Consequently, there would be major delays associated with attempting to scan more ...New Report Just Published: World Prostate Cancer Therapeutics Market Report
... II-11 Complicated Treatment Protocols: A major Stumbling Block in Patient Compliance II-11 ... 3. Product Overview II-17 Cancer: A major Health Crises in the Modern World II-17 ... Graph/Chart) III-2 Cost of Cancer Drugs - A major Concern in the US III-2 Market Accelerators ...deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
... to increased calcium excretion in urine, a major risk factor for kidney stones and also a sign of ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ... for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for ...Pharmaceutical Institute Launches New E-Course Focused on Health Policy
... played by both commercial health plans and the major government insurance programs are explored. ... Reform Options -- For the first time in decades, major health insurance reform is at the top of the ... learning solutions for professionals within all major pharmaceutical company functions including Brand ...deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation
... genetic risk factors for diseases with a major impact on public health, and in bringing to ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ... for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for ...Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States
... also become part of a larger effort organized by major League Baseball (MLB) to integrate awareness ... of Lou Gehrig's disease and outlining how major League Baseball could help. major League Baseball's response was immediate and, the ...deCODE genetics Announces First Quarter 2009 Financial Results
... of the year deCODE has extended its list of major gene discoveries. In January, deCODE ... factor for essential tremor, as well as major risk factors for thyroid cancer. deCODE has ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ...deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
... to deCODE's genetic markers for increased risk of major cardiovascular and metabolic diseases, including ... risk of AF(3), a common cardiac arrhythmia and a major cause of cardiogenic stroke. Testing for ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ...Publication of Shire plc's Annual Report 2008
... Pharmaceuticals product sales are made to major pharmaceutical wholesale distributors as well as ... by fluctuations in the buying patterns of major distributors and other trade buyers. These ... general economic conditions in any of the Group's major markets may also affect the Group's sales, ...ThromboGenics Announces Business Update and 2008 Full Year Results
... single injection post surgery, could overcome the major drawbacks such as bleeding and the need for ... Corporate highlights major partnering deal: In June 2008, ThromboGenics and ... in patients with back of the eye disease is a major milestone for the Company. Our decision ...Cord Blood America Restructures Debt; Projects to be Cash Flow Positive
... outstanding debt. "The restructuring is a major step forward for Cord Blood America. With the ... to our shareholders that reducing debt is a major focus in 2009," Mr. Schissler said. "This ... in treating diabetes, heart disease, and other major diseases will dramatically increase the number of ...Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe
... for the treatment of adult patients with major depressive episodes. "There is still great ... the 33 million people in Europe suffering from major depressive episode. Valdoxan's powerful ... a more complete remission." Valdoxan: a major therapeutic advance in management of depression ...Mosquito genes linked to insecticide resistance may be new target in fight against malaria
... in the mosquito Anopheles funestus , one of the major malarial vectors in Africa. The group studied ... resistance in Anopheles gambiae , the other major malaria-carrying mosquito in Africa. "If the ... be effective at overcoming resistance in both major malaria vectors," said Ranson. Furthermore, ...Introducing deCODEme Cardio(TM) and deCODEme Cancer(TM)
... scans for assessing personal risk of several major cardiovascular diseases and common cancers. ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ... for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for ...USC researchers derive first embryonic stem cells from rats
... 26 issue of the journal Cell . "This is a major development in stem cell research because we know ... long sought by researchers around the world, is a major advance in biomedical science," says Martin Pera, ... knockout rat models," he says. "This will have a major impact on the future of biomedical research." ...Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons
... Dr. Olkowski has written two articles for major peer-reviewed eye journals as well as many ... reviewed articles and has made 5 presentations at major eye meetings and numerous presentations at local ... for manufacturers and academic appointments at major universities), publications and lectures (to ...Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
... with customers around the world, including major biotechnology/pharmaceutical companies and ... human antibody therapeutic market starting with major pre-clinical work on multiple targets in 2009. ... promises of biologics by developing RabMAb as a major therapeutic antibody discovery platform. We have ...